Received Sep 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y014437 | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y011018 | — |
no additional adverse event reported; Inbound call from nurse who reports a 14 month old was given VARIVAX and PROQUAD on the same day, one vaccine in each leg. Date of administration was 7/30/2025 and there have been no reported side effects or symptoms at this time. No additional AE de; Information has been received from Business Partner/CRO on 11-Aug-2025. This spontaneous report was received from a Other health professional and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 30-Jul-2025, the patient started therapy with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y014437, expiration date: 22-Feb-2026) for an unknown indication. On 30-Jul-2025, the patient started therapy with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX REFRIGERATOR STABLE), (lot #Y011018, expiration date: 18-Jun-2026) for an unknown indication. On 30-Jul-2025, the patient started therapy with sterile diluent (MERCK STERILE DILUENT), (indication, expiration date, and lot # were not reported). On 30-Jul-2025, the patient started therapy with sterile diluent (MERCK STERILE DILUENT), (indication, expiration date, and lot # were not reported) (Overdose). No additional adverse event reported.
sterile diluent; sterile diluent